Cutting-edge technology for breast cancer screening

Diagnostic-as-a-Service

that women need

Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine

The Problem

1 In 8 Women

will have breast cancer
at least once

BC is the most treatable cancer

but women, specially those with dense breast tissue, do not have reliable
screening methods available

It still remains the #1 cancer killer for women

81% of them want to get tested
for breast cancer

The Solution

We’re building a pain-free, radiation-free and accessible breast cancer test for them

Proof of concept data

Sensitivity
Accuracy
Specificity
Sensitivity
Accuracy
Specificity

Our
Mission

Women aged 20-49 cannot get screened for breast cancer because existing solutions are unreliable. However, they want to, and are ready to pay for it. At “The Blue Box”, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 88.33%.

Our
Mission

Breast cancer is the most treatable cancer, yet it remains the #1 cancer killer for women, as 50% are detected too late. At The Blue Box, we’ve built a urine-based breast cancer test with a sensitivity of 88.42%, outperforming mammography by 15%-30%. We’ll run clinical trials in 2025 and launch in gynecology clinics by 2026.

Scientific Validation

Currently collaborating with 7 hospitals, with over 450 women having participated in our study

The Blue Box - Featured at

Key Opinion Leaders are Supporting Us

“WomEC will revolutionize uterine cancer
diagnosis in the world”
Javier F. Magrina,
Director Gynecologic Oncology
“From a clinical perspective, the project is expected to benefit the European community”
Frederic Amant,
Head of the gynecology oncology department, ex-chairman of the ENITEC consortium

Join The Blue Box Family!

Do you want to be the first to know when The Blue Box will hit the market?

Subscribe to our newsletter and never miss out on The Blue Box journey!

Scroll to Top

By clicking the “continue” button below and accessing the next page, the reader is declares she/he is clinician or scientific personnel and, therefore, can understand the content

Contact us

Join The Blue Box Family!

Do you want to be the first to know when The Blue Box will hit the market? Subscribe to our newsletter and never miss out on The Blue Box journey!